Health
Viral ‘molecular scissor’ is next COVID-19 drug target: Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins – Benzinga
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the …
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the infection, researchers at The University of Texas Health Science Center at San Antonio and the Wroclaw University of Science and Technology discovered.
SAN ANTONIO (PRWEB) October 18, 2020
American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design blocking a molecular “scissor” tha…
-
Noosa News13 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News18 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News20 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common
-
Noosa News21 hours agoCountdown on for Noosa Eat & Drink Festival 2025